JPMorgan Chase & Co’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,312	Closed	-$175K	–	6789
2023 Q4	$175K	Buy	+12,312	New	+$175K	﹤0.01%	4516
2023 Q3	–	Sell	-157,858	Closed	-$2.6M	–	6698
2023 Q2	$2.6M	Buy	+157,858	New	+$2.6M	﹤0.01%	2885